Table of Contents

1. Introduction

 1.1 Companion Diagnostics Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Companion Diagnostics Market Snapshot

 2.2 Companion Diagnostics Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Companion Diagnostics Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Companion Diagnostics Market Size By Technology

  2.3.2 Companion Diagnostics Market Size By Indication

  2.3.3 Companion Diagnostics Market Size By End-user

 2.4 Companion Diagnostics Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Companion Diagnostics Market Overview

 3.1 Companion Diagnostics Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Companion Diagnostics Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Companion Diagnostics Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Companion Diagnostics Market Overview

 3.7 Companion Diagnostics Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Average Pricing by Technology Type

  4.1.3 Price Benchmarking by Key Market Participants

  4.1.4 Regional Pricing Variations and Accessibility Metrics

  4.1.5 Emerging Pricing Strategies and Reimbursement Models

4.2 Regulatory & Compliance Landscape

  4.2.1 Overview

  4.2.2 Regulatory Frameworks for Companion Diagnostics Approval

  4.2.3 Clinical Validation and Compliance Requirements

  4.2.4 Government Policies Supporting Precision Medicine

  4.2.5 Risk Management and Quality Standards

4.3 Technology & Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Trends of Molecular Diagnostic Technologies

  4.3.3 Investment in Genomic and Biomarker Research

  4.3.4 Patent Activity and Innovation Landscape

  4.3.5 Emerging Trends in Personalized Diagnostics

4.4 Operational & Clinical Metrics

  4.4.1 Overview

  4.4.2 Number of Companion Diagnostic Tests Approved Annually

  4.4.3 Diagnostic Accuracy and Clinical Utility Metrics

  4.4.4 Turnaround Time and Testing Efficiency

  4.4.5 Quality Assurance and Laboratory Standards

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Funding and Investments in Precision Medicine

  4.5.3 M&A and Strategic Collaborations

  4.5.4 Partnerships Between Pharma and Diagnostic Companies

  4.5.5 Emerging Innovation Hubs and Research Centers

5. Companion Diagnostics Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Polymerase Chain Reaction

  5.2.1 Key Trends

  5.2.2 Companion Diagnostics Market Size & Forecast, 2022–2035

 5.3 Immunohistochemistry

 5.4 In-situ Hybridization

 5.5 Next Generation Gene Sequencing

 5.6 Others

6. Companion Diagnostics Market Segmental Analysis & Forecast, By Indication, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Cancer

  6.2.1 Key Trends

  6.2.2 Companion Diagnostics Market Size & Forecast, 2022–2035

 6.3 Neurological Diseases

 6.4 Infectious Diseases

 6.5 Others

7. Companion Diagnostics Market Segmental Analysis & Forecast, By End-user, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Pharmaceutical & Biopharmaceutical Companies

  7.2.1 Key Trends

  7.2.2 Companion Diagnostics Market Size & Forecast, 2022–2035

 7.3 Reference Laboratories

 7.4 Contract Research Organizations (CROs)

8. Companion Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Companion Diagnostics Market Size & Forecast, By Technology, 2022–2035

 8.2.3 Companion Diagnostics Market Size & Forecast, By Indication, 2022–2035

 8.2.4 Companion Diagnostics Market Size & Forecast, By End-user, 2022–2035

 8.2.5 Companion Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Companion Diagnostics Market Size & Forecast, By Technology, 2022–2035

 8.3.3 Companion Diagnostics Market Size & Forecast, By Indication, 2022–2035

 8.3.4 Companion Diagnostics Market Size & Forecast, By End-user, 2022–2035

 8.3.5 Companion Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Companion Diagnostics Market Size & Forecast, By Technology, 2022–2035

 8.4.3 Companion Diagnostics Market Size & Forecast, By Indication, 2022–2035

 8.4.4 Companion Diagnostics Market Size & Forecast, By End-user, 2022–2035

 8.4.5 Companion Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Companion Diagnostics Market Size & Forecast, By Technology, 2022–2035

 8.5.3 Companion Diagnostics Market Size & Forecast, By Indication, 2022–2035

 8.5.4 Companion Diagnostics Market Size & Forecast, By End-user, 2022–2035

 8.5.5 Companion Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Mexico

  8.5.5.3 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Companion Diagnostics Market Size & Forecast, By Technology, 2022–2035

 8.6.3 Companion Diagnostics Market Size & Forecast, By Indication, 2022–2035

 8.6.4 Companion Diagnostics Market Size & Forecast, By End-user, 2022–2035

 8.6.5 Companion Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 South Africa

  8.6.5.4 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Companion Diagnostics Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 F. Hoffmann-La Roche Ltd.

 9.6.1.1 Company Overview & Snapshot

 9.6.1.2 Product/Service Portfolio

 9.6.1.3 Key Company Financials

 9.6.1.4 SWOT Analysis

9.6.2 QIAGEN N.V.

9.6.3 Agilent Technologies, Inc.

9.6.4 Thermo Fisher Scientific Inc.

9.6.5 Abbott Laboratories

9.6.6 Illumina, Inc.

9.6.7 bioMérieux SA

9.6.8 Danaher Corporation

9.6.9 Myriad Genetics, Inc.

9.6.10 Guardant Health, Inc.

9.6.11 Foundation Medicine, Inc.

9.6.12 Sysmex Corporation

9.6.13 Bio-Rad Laboratories, Inc.

9.6.14 Hologic, Inc.

9.6.15 Invitae Corporation

9.6.16 NeoGenomics Laboratories, Inc.

9.6.17 Exact Sciences Corporation

9.6.18 Fujirebio Diagnostics, Inc.

9.6.19 ArcherDX, Inc.

9.6.20 Genomic Health, Inc.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Companion Diagnostics Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Companion Diagnostics Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures